Dr. Ford completed his medical degree at the University of Birmingham and post graduate training in the region. Dr. Ford then completed specialist training in prestigious London teaching hospitals before returning to the West Midlands where he has been a consultant for over 13 years. His NHS practice is based at the Queen Elizabeth Hospital Birmingham, and is well experienced in all aspects of Uro-oncology treatment and management. He has previously been the clinical lead for the Radiotherapy and Oncology departments of the hospital developing services in both departments during this time as well as managing his oncology consultant colleagues. His work includes being the local lead of the PACE trial looking at profound hypofractionation techniques for localized prostate cancer and helping to advance SABR (stereotactic ablative radiotherapy), precision technology originally developed for brain and lung cancer, now being applied to other areas such as metastatic prostate cancer. He is experienced in providing and evaluating all oncological treatments for prostate, kidney and bladder cancer including hormonal therapies, chemotherapy, immunotherapy, radiotherapy, MRLinac, SABR and prostate brachytherapy. Dr. Ford is actively involved in and deeply committed to cancer research. He is a deputy clinical cancer lead for the West Midlands NIHR Clinical Research Network, whose role is to support and promote research activity across the region.